Author

J . Li

Institution: Bristol-Myers Squibb (United States)

Observed institution: Bristol-Myers Squibb (United States)

OpenAlex ID: A5065311734

Induction R2 Followed by Maintenance in Patients With Relapsed/refractory Transformed Follicular Lymphoma: Interim Analysis From the Phase 3b Magnify Study

2021 · F . Lansigan, V . Parameswaran, et al. · Hematological Oncology

Works count: 1

Citation count:

H-index:

I10-index: